Moderators: Journalist Lars Frick (Börsveckan)
Sector: Health care - Pharmaceuticals & Biotechnology
Activity: Capital Markets Seminar
Language: English
Agenda BioInvent R&D Day December 8, 2022
14:00-14:10 Welcome & introduction Martin Welschof, CEO
14:10-15:00 FcyRIIB clinical programs
BI-1206 and BI-1607 Björn Frendéus, CSO & Andres McAllister, CMO
Break
15:15-15:30 The oncolytic drug candidate BT-001
(anti-CTLA-4) Björn Frendéus, CSO & Andres McAllister, CMO
15:30-15:45 BI-1808 (anti-TNFR2) Björn Frendéus, CSO & Andres McAllister, CMO
15:45-16:05 “Current treatment landscape and unmet medical need in T cell lymphoma” KOL Dr Sean Lim
16:05-16:25 Fire-side chat/Q&A session with presenters, led by
moderator Lars Frick
16:30 Networking, food & drinks